Minimize
 

RTOG 0612 Protocol Information

Minimize
Investigating Markers of Radiation Outcome in Patients with Intermediate-Risk Prostate Cancer Using DNA Microarray Analysis: An RTOG Pilot Study
Protocol Documents
Current Version Date: 10/9/2009
Principal Investigator: Arnab Chakravarti MD
Primary Objective:

To demonstrate feasibility of acquiring specimens, both frozen and paraffin embedded, to yield RNA of adequate quality to perform DNA microarray studies within the multi-institutional setting.

Patient Population:

Patients eligible and enrolled on RTOG 0232.

Target Accrual: 156
Current Accrual: 13
Status: Terminated
Date: 11/5/2013
Participating Sites:
Emory University Hospital Midtown Atlanta GA
Emory University Hospital/Winship Cancer Institute Atlanta GA
Fox Chase Cancer Center Philadelphia PA
Goshen Center for Cancer Care Goshen IN
Grady Health System Atlanta GA
Gundersen Lutheran Medical Center La Crosse WI
Kansas City CCOP Prairie Village KS
Liberty Hospital Liberty MO
Montefiore Medical Center - Moses Campus Bronx NY
Ohio State University Medical Center Columbus OH
OhioHealth Mansfield Hospital Mansfield OH
Siteman Cancer Center at Saint Peters Hospital St. Peters MO
Siteman Cancer Center at West County Hospital St. Louis MO
St Johns Hospital, Cancer Institute Springfield IL
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami FL
Washington University School of Medicine St. Louis MO
Updated: 11/15/2013

You must be logged in to view this file.

Login  |  Close

You must be logged in to view this file.

Login  |  Close